The protein tyrosine phosphatase, non-receptor type 22 R620W polymorphism does not confer susceptibility to psoriasis in the genetic homogeneous population of Crete

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 1, 2010, Pages 107-111

  Zervou, Maria I ^a   Castro Giner, Francesc ^b,c,d   Sidiropoulos, Prodromos ^e   Boumpas, Dimitrios T ^e   Tosca, Androniki D ^a   Krueger Krasagakis, Sabine ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN TYROSINE PHOSPHATASE;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETICS; GREECE; HUMAN; MAJOR CLINICAL STUDY; NORMAL HUMAN; ONSET AGE; PROTEIN POLYMORPHISM; PSORIASIS; PSORIATIC ARTHRITIS; SEX DETERMINATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AMINO ACID SUBSTITUTION; ARTHRITIS, PSORIATIC; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GREECE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; PSORIASIS; STAT4 TRANSCRIPTION FACTOR;

EID: 76949093877     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2009.0130     Document Type: Article

References (40)

1. Begovich AB, Caillier SJ, Alexander HC, et al. (2005) The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet 76: 184-187.
2. Begovich AB, Carlton VE, Honigberg LA, et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75:330-337.
3. Bottini N, Musumeci L, Alonso A, et al. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36:337-338.
4. Bottini N, Vang T, Cucca F, et al. (2006) Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 18: 207-213.
5. Bowcock AM, Cookson WO (2004) The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 13 Spec No 1:R43-R55.
6. Campalani E, Barker JNWN (2005) The clinical genetics of psoriasis. Curr Genomics 6:51-60.
7. Criswell LA, Pfeiffer KA, Lum RF, et al. (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76: 561-571.
8. Ghoreschi K, Mrowietz U, Röcken M (2003) A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses. J Mol Med 81:471-480.
9. Gregersen PK, Lee HS, Batliwalla F, et al. (2006) PTPN22: setting thresholds for autoimmunity. Semin Immunol 18:214-223.
10. Gregersen PK, Olsson LM (2009) Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 27:363-391.
11. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263-271.
12. Hasegawa K, Martin F, Huang G, et al. (2004) PEST domainenriched tyrosine phosphatase (PEP) regulation of effector= memory T cells. Science 303:685-689.
13. Helliwell P, TaylorWJ (2005) Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 64 (Suppl 2):ii3-8.
14. Hinks A, Barton A, John S, et al. (2005) Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 52:1694-1699.
15. Hü ffmeier U, Reis A, Steffens M, et al. (2006a) Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis. J Invest Dermatol 126:932-935.
16. Hü ffmeier U, Steffens M, Burkhardt H, et al. (2006b) Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients. J Med Genet 43:517-522.
17. Jagiello P, Aries P, Arning L, et al. (2005) The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 52:4039-4043.
18. Kahles H, Ramos-Lopez E, Lange B, et al. (2005) Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol 153:895-899.
19. Korman BD, Alba MI, Le JM, et al. (2008) Variant form of STAT4 is associated with primary Sjö gren's syndrome. Genes Immun 9:267-270.
20. Lee YH, Rho YH, Choi SJ, et al. (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases-a metaanalysis. Rheumatology (Oxford) 46:49-56.
21. Li Y, Liao W, Chang M, et al. (2009) Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22. J Invest Dermatol 129:629-634.
22. Martínez A, Varadé J, Márquez A, et al. (2008) Association of the STAT4 gene with increased susceptibility for some immunemediated diseases. Arthritis Rheum 58:2598-2602.
23. Matesanz F, Rueda B, Orozco G, et al. (2005) Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. J Neurol 252:994-995.
24. Nair RP, Stuart PE, Nistor I, et al. (2006) Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 78:827-851.
25. Nistor I, Nair RP, Stuart P, et al. (2005) Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association. J Invest Dermatol 125:395-396.
26. Orozco G, Sanchez E, Gonzalez-Gay MA, et al. (2005) Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52:219-224. (Pubitemid 40129251)
27. Prescott NJ, Fisher SA, Onnie C, et al. (2005) A general autoimmunity gene (PTPN22) is not associated with inflammatory bowel disease in a British population. Tissue Antigens 66:318-320.
28. Remmers EF, Plenge RM, Lee AT, et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357:977-986.
29. Rueda B, Nunez C, Orozco G, et al. (2005) C1858T functional variant of PTPN22 gene is not associated with celiac disease genetic predisposition. Hum Immunol 66:848-852.
30. Skórka A, Bednarczuk T, Bar-Andziak E, et al. (2005) Lymphoid tyrosine phosphatase (PTPN22=LYP) variant andGraves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol 62:679-682.
31. Smith RL, Warren RB, Eyre S, et al. (2008) Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. Br J Dermatol 158:962-968.
32. Smyth D, Cooper JD, Collins JE, et al. (2004) Replication of an association between the lymphoid tyrosine phosphatase locus (LYP=PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53:3020-3023.
33. Vandiedonck C, Capdevielle C, Giraud M, et al. (2006) Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol 59:404-407.
34. Vang T, Congia M, Macis MD, et al. (2005) Autoimmuneassociated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37:1317-1319.
35. van Oene M, Wintle RF, Liu X, et al. (2005) Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 52:1993-1998.
36. Velaga MR, Wilson V, Jennings CE, et al. (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is amajor determinant ofGraves' disease. J Clin Endocrinol Metab 89:5862-5865.
37. Wagenleiter SE, Klein W, Griga T, et al. (2005)Acase-control study of tyrosine phosphatase (PTPN22) confirms the lack of association with Crohn's disease. Int J Immunogenet 32:323-324.
38. Zervou MI, Goulielmos GN, Castro-Giner F, et al. (2009) STAT4 gene polymorphism is associated with psoriasis in the genetically homogeneous population of Crete, Greece. Hum Immunol 70:738-741.
39. Zervou MI, Mamoulakis D, Panierakis C, et al. (2008) STAT4: a risk factor for type 1 diabetes? Hum Immunol 69:647-650.
40. Zhernakova A, van Diemen CC, Wijmenga C (2009) Detecting shared pathogenesis from the shared genetics of immunerelated diseases. Nat Rev Genet 10:43-55.